IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.
about
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusRecent vaccine development for human metapneumovirusThe impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinovirusesA novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent modelsT cell-mediated host immune defenses in the lungDetermining the breadth of the respiratory syncytial virus-specific T cell responseLive attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responsesmCLCA3 modulates IL-17 and CXCL-1 induction and leukocyte recruitment in murine Staphylococcus aureus pneumonia.Viral disruption of olfactory progenitors is exacerbated in allergic mice.Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.Immunity to RSV in Early-Life.Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infectionAntiviral B cell and T cell immunity in the lungs.Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosaProtective and dysregulated T cell immunity in RSV infectionToward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthmaLocal IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infectionImpaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infantsRespiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathologyCross-sectional study of the relationship of peripheral blood cell profiles with severity of infection by adenovirus type 55.Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophagesThe Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice.Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection.Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeuticsMechanisms of respiratory syncytial virus modulation of airway immune responses.STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung.Universal vaccine against respiratory syncytial virus A and B subtypes.Endogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in miceInflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial virusesImmunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus ClearanceIL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation.STAT5-induced lunatic fringe during Th2 development alters delta-like 4-mediated Th2 cytokine production in respiratory syncytial virus-exacerbated airway allergic diseaseRespiratory syncytial virus infection, TLR3 ligands, and proinflammatory cytokines induce CD161 ligand LLT1 expression on the respiratory epitheliumAttenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.
P2860
Q26748856-DBB2F4A6-EE61-4A7C-9389-54637CD10313Q27023742-7FA901F3-E4BA-4794-91ED-2AB1F6296918Q27026381-11DA589B-89BA-4E40-A49F-3B5EDFC324FBQ27312129-8C9CFE39-D7BE-4961-81D9-CB0ED008F244Q28395374-49F6C033-B293-4DCB-A074-C48AA5501CFAQ30411070-5EA9095A-48A2-453A-9486-CA7BCB5FDBC1Q33812212-498468B1-2323-466C-A5E5-AB418814D1A6Q33916302-A54A8C40-0D6D-42B7-B51A-714204D0E5DBQ34029786-61D2C32C-9433-4127-BE37-84DDAB45C886Q34033869-C875C7F9-34D7-4499-82A1-A4F3B2C239ACQ34264615-AF393D01-62F9-415D-A974-EEA429E3C368Q34305520-AC3E20E9-EC0F-4909-86A7-1598BC6BD7FBQ34454614-CB364F5A-5518-4D43-B18D-3932BED9494CQ34526149-FDCA9D58-156F-4A40-81E7-3AE5B3AA8666Q34527023-8F77E10C-1BFC-45F5-B8D3-140FF351D88BQ34964939-B91E4777-62DC-47F9-8C2E-01EAE40AD13DQ34987105-BC78B693-22A4-48CB-B007-B7CE7FFC1FFEQ35032594-F1B17B81-E65E-4302-84F4-72D9B843E3A2Q35070461-59CD5D9C-8866-43F2-9BE2-955103D5A026Q35099663-82983E87-B3D7-400F-9AC2-5DB5715C2A71Q35124686-AF2C52F0-E774-41B5-819C-0E1FC17473F9Q35185439-F09F3962-3B98-421A-91C9-62328FA3F8A1Q35207665-735C6094-3122-4032-9E83-21A614EBFAA2Q35688253-38BE6D8A-BB4F-4472-9FC9-76AB450C3E8CQ35868095-5252CAB7-1734-48D9-A71A-6F4F62DE0E43Q35940965-65B21A18-3946-4360-82C7-CC78C9140F90Q35941010-946EE243-FE27-4D07-9189-5D60265B7F7EQ35945802-48CE4C43-AB19-413A-A859-E4E8AACC04CDQ36174346-FBE1A72C-668B-4D32-B9CF-3FB836BE9916Q36203787-8FF5003D-E46C-4A01-B3DF-6F9C93B3F9ADQ36331149-BA36CC9A-8940-4170-84B5-6AE6073FDFA8Q36338294-9007C7A9-504A-44EF-9082-4C2B92583AD9Q36723988-51EDAAB6-0A8F-49A2-9E3C-42ACD0C640D1Q37057787-3C26D7AD-C027-4CD4-B37C-530E4849B46CQ37130834-CBF8727A-5F8B-4839-A854-17EDC9BA797AQ37512884-D970321C-76AC-4546-97A3-871478D77F88Q37562241-8083A20F-931F-480F-9B4A-B8FC55DD58B6Q37625393-4434109C-CB23-4F8E-829E-B1A417FF7862Q37644018-2E1F4F77-EB94-4D01-8412-A5122CDFAE43Q37698331-2DB702E8-AF60-415D-9955-0899D1A1B1B3
P2860
IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@ast
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@en
type
label
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@ast
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@en
prefLabel
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@ast
IL-17-induced pulmonary pathog ...... cerbation of allergic disease.
@en
P2093
P2860
P1476
IL-17-induced pulmonary pathog ...... acerbation of allergic disease
@en
P2093
Aaron A Berlin
Dennis M Lindell
Marc B Hershenson
Nicholas W Lukacs
Sumanta Mukherjee
Susan B Morris
P2860
P304
P356
10.1016/J.AJPATH.2011.03.003
P407
P577
2011-05-03T00:00:00Z